Back to company

JJ PHARMA CONSULT ApS: Financial statements 2016

CVR: 33257635

JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -44,704 and a net result of DKK 315,296 compared with DKK 582,439 the year before. Equity amounted to DKK 1,630,349. The solvency ratio was 99%.

Gross Profit
-44,704 kr.
Profit/Loss
315,296 kr.
Equity
1,630,349 kr.
Total Assets
1,646,656 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016--45 t.315 t.1.6 mio.-
2015--17 t.582 t.1.4 mio.-
2014--23 t.920 t.934 t.-
2013--9 t.95 t.183 t.-
2012--6 t.22 t.89 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is JJ PHARMA CONSULT ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

JJ PHARMA CONSULT ApS: The 2015 annual report is outMay 30, 2016

JJ PHARMA CONSULT ApS has published its annual report for 2015. Gross profit came to DKK -17,398, and the net result was DKK 582,439.

About JJ PHARMA CONSULT ApS

JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity amounted to DKK 16,917,153.